Identifying H/ACA Box 20 as A Potential Drug Target Or Biomarker

Target Name: SNORA20

NCBI ID: G677806

SNORA20

Other Name(s): small nucleolar RNA, H/ACA box 20 | ACA20 | Small nucleolar RNA, H/ACA box 20

Identifying H/ACA Box 20 as A Potential Drug Target Or Biomarker

SNORA20, also known as small nucleolar RNA (snRNA), is a non-coding RNA molecule that plays a critical role in the regulation of gene expression in various organisms, including humans. H/ACA box 20, specifically, is a specific location on the snRNA molecule that has been identified as a potential drug target or biomarker.

The H/ACA box is a conserved region that is located at the base pair 680-700 of each exon in human snRNAs. It is composed of 19 amino acids and has been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis, and translation of RNA molecules.

One of the unique features of the H/ACA box is its ability to interact with other molecules, including histones and non-histone proteins. This interaction has been shown to play a role in the regulation of gene expression and has led to the suggestion that it may be a potential drug target or biomarker.

In addition to its role in gene regulation, the H/ACA box has also been shown to play a role in the development and progression of various diseases, including cancer. For example, studies have shown that expression levels of the H/ACA box is often increased in various types of cancer, and that inhibition of its expression has been shown to have therapeutic benefits in these diseases.

Furthermore, the H/ACA box has also been shown to be involved in the regulation of cellular signaling pathways. For example, it has been shown to play a role in the regulation of the TGF-β pathway, a pathway that is involved in cell growth, differentiation, and apoptosis.

In conclusion, the H/ACA box 20 is a unique and conserved region of the snRNA molecule that has been identified as a potential drug target or biomarker. Its role in gene regulation, disease development, and cellular signaling pathways make it an attractive target for further research and potential therapeutic applications.

While further studies are needed to fully understand the implications of the H/ACA box 20 as a drug target or biomarker, its potential impact on human health is significant. As research continues to progress, it will be exciting to see if the H/ACA box 20 will ultimately be proven to be a valuable tool for the treatment of various diseases.

Protein Name: Small Nucleolar RNA, H/ACA Box 20

The "SNORA20 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORA20 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets